Big Pharma Lied About Serotonin Reuptake Inhibitors, Study Finds


The reality that Big Pharma is just a business here to make money is a hard pill to swallow, and that fact that it liked about the dangers Serotonin Reuptake Inhibitors (anti-depressants) comes as no surprise.

“The medical profession is being bought by the pharmaceutical industry, not only regarding the practice of medicine but also regarding teaching and research.

The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful.” – Arnold Seymour Relman (1923-2014), Harvard Professor of Medicine and Former Editor-in-Chief of the New England Medical Journal.

A more recent example of corruption and lies emanating from Big Pharma comes from a study which was published b British Medical Journal by researchers at the Nordic Cochrane Center in Copenhagen.


The shocking study revealed that pharmaceutical companies were not disclosing the full information on the results of their drugs trials of Serotonin Reuptake Inhibitors.

Researchers looked at documents from 70 different double-blind, placebo-controlled trials of selective serotonin reuptake inhibitors (SSRI) and serotonin reuptake inhibitors (SNRI) finding the full extent of harm the clinical study failed to report.

Tamang Sharma, a Ph.D. student at Cochrane and lead author of the study, stated:

We found that a great deal of the appendices was frequently only available upon request to the authorities, and the authorities had never requested them. I really type of scared about how bad the actual scenario would be if we had the complete data. (source).

[This study] confirms that the full degree of damage of antidepressants is not reported.

They are not reported in the published literature, we know that– and it appears that they are not effectively reported in medical research study reports that go to the regulators and from the basis of decisions about licensing. (source).

Peter Gotzsche, a clinician researcher at Cochrane and the co-author of the study, really attempted to access to medical trial reports practically a decade ago for anti-obesity tablets.

Sadly, the European Medicines Agency (EMA) denied them the reports.

They spoke about commercial privacy although there was absolutely nothing in these reports that was commercially confidential.

We explained that all this secrecy cost human lives, but they weren’t thinking about that at all.

Serotonin Reuptake Inhibitors – the truth

It took years of demands and grievances for this to occur and, while Gotzsche is pleased they were able to accomplish this breakthrough, he reminds us that comparable development has yet to made in the United States.

He went on to state that scientists need better access to data from scientific trials to carry out evaluations unobstructed by industry impact:

It’s profoundly unethical when patients volunteer to benefit science and then we let drug business decide that we can not get access to the raw data. The screening of drugs must be a public business.

Moncrieff (quoted above) then goes on to express further issues:

We really do not have sufficient proof that antidepressants are useful and we have increasing evidence that they can be hazardous. So we need to go into reverse and stop this increasing pattern of prescribing Serotonin Reuptake Inhibitors.

This Is Not The First Time

This is not the first time that pharmaceutical business has been caught manipulating science in order to get antidepressants onto the shelves.

It was only a few months ago that an independent review found that the commonly prescribed antidepressant drug Paxil (paroxetine) is not safe for teens, even though a big quantity of literature had already recommended this formerly.

The 2001 drug trial that took place, moneyed by GlaxoSmithKline, found that these drugs were entirely safe, and used that ‘science’ to market Paxil as safe for teens.

John Ioannidis, an epidemiologist at Stanford University School of Medicine and co-author of the study, is also the author of the most widely accessed short article in the history of the general public Library of Science (PLoS), entitled Why Most Published Research Findings Are False.

In the report, he specifies that “most current released research study findings are false.”

And this was more than 10 years earlier– the circumstance has undeniably intensified in the interim.

This echoes the words of Dr. Richard Horton, the present Editor-In-Chief of one of the most reputable evaluated medical journals worldwide.

The case against science is straightforward: much of the clinical literature, possibly half, might merely be false. Afflicted by research studies with little sample sizes, small effects, void exploratory analyses, and flagrant disputes of interest, together with a fixation for pursuing stylish trends of dubious importance, science has taken a turn towards darkness. (source).

The Editor in Chief of the New England Medical Journal, which is likewise thought about to be among the best in the world, has actually made similar assertions.

It is merely no longer possible to believe much of the clinical research study that is published or to rely on the judgment of trusted physicians or reliable medical standards.

I take no satisfaction in this conclusion, which I reached gradually and hesitantly over my 20 years as an editor of the New England Journal of Medicine. (source).

A few years earlier, Lucia Tomljenovic, a PhD in biochemistry and a senior postdoctoral fellow in UBC’s Faculty of Medicine, exposed files that expose vaccine makers, pharmaceutical business, and health authorities have known about several threats connected with vaccines but opted to withhold them from the general public.

The files were acquired from the UK Department of Health (DH) and the Joint Committee on Vaccination and Immunization (JCVI), who advise the Secretaries of State for Health in the UK about illness preventable through immunizations.

The JCVI made “continuous efforts to keep vital data on extreme unfavorable reactions and contraindications to vaccinations to both parents and health practitioners in order to reach overall vaccination rates.”

The transcripts of the JCBI conferences likewise show that a few of the Committee members had extensive ties to pharmaceutical companies which the JCVI regularly co-operated with vaccine manufacturers on the strategies targeted at enhancing vaccine uptake.

Some of the meetings at which such questionable products were discussed were not meant to be publicly offered, as the transcripts were just launched later, through the Freedom of Information Act (FOI).

These particular meetings are signified in the records as “commercial in confidence,” and expose a clear and troubling absence of transparency, as a few of the info was gotten rid of from the text (i.e., the names of the participants) prior to transcript release under the FOI area at the JCVI website. (source).

Below is a clip is taken from the One More Girl documentary, a film which looks at the Gardasil vaccine, a medication developed to prevent Human Papillomavirus.

In it, Dr. Peter Rost, MD, a previous vice president of one of the biggest pharmaceutical companies on the planet (Pfizer), shares the truth about the ties in between the medical and pharmaceutical industry.

Rost is a former vice president of Pfizer, and a whistleblower of the whole pharmaceutical market in general.

He is the author of The Whistleblower, Confessions of a Healthcare Hitman. Considering his work experience, it would be an understatement to say that he is an insider professional on huge pharma marketing.



You may also like